Cell therapy with polarized macrophages for tissue regeneration

The invention provides an in vitro method for inducing macrophage polarization to an M2 phenotype useful for tissue repair. The method described in the present invention comprises the in vitro exposure of macrophages to repeated series of hypoxia- reoxygenation. Activated M2 macrophages obtained by...

Full description

Saved in:
Bibliographic Details
Main Authors García De La Riva Mestre, Pablo, Hotter Corripio, María Georgina, Sánchez Moreno, Jaime, Sola Martínez, Ana María, Martín Cordero, Jorge Vicente, Domínguez Sánchez, Rubén, Ginesta Buch, Xavier, Rodríguez García, Anna, Castillo García, Adrián
Format Patent
LanguageEnglish
Published 16.11.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention provides an in vitro method for inducing macrophage polarization to an M2 phenotype useful for tissue repair. The method described in the present invention comprises the in vitro exposure of macrophages to repeated series of hypoxia- reoxygenation. Activated M2 macrophages obtained by this method overexpress molecules important for tissue remodeling and amelioration of inflammation, such as NGAL and anti-inflammatory cytokines (IL-10). Thus, M2 macrophages obtained by this method are useful as cell therapy for tissue regeneration. The invention also provides pharmaceutical compositions and kits comprising the M2 macrophages obtained by the described method. The invention further refers to a device for inducing hypoxia and re- oxygenation conditions on isolated macrophages according to the described method.
Bibliography:Application Number: AU20170330079